Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 386

1.

Highly efficient head-only magnetic field insert gradient coil for achieving simultaneous high gradient amplitude and slew rate at 3.0T (MAGNUS) for brain microstructure imaging.

Foo TKF, Tan ET, Vermilyea ME, Hua Y, Fiveland EW, Piel JE, Park K, Ricci J, Thompson PS, Graziani D, Conte G, Kagan A, Bai Y, Vasil C, Tarasek M, Yeo DTB, Snell F, Lee D, Dean A, DeMarco JK, Shih RY, Hood MN, Chae H, Ho VB.

Magn Reson Med. 2019 Nov 25. doi: 10.1002/mrm.28087. [Epub ahead of print]

PMID:
31763726
2.

A nationwide cohort study on treatment and survival in patients with malignant peripheral nerve sheath tumours.

Martin E, Coert JH, Flucke UE, Slooff WM, Ho VKY, van der Graaf WT, van Dalen T, van de Sande MAJ, van Houdt WJ, Grünhagen DJ, Verhoef C.

Eur J Cancer. 2019 Nov 21;124:77-87. doi: 10.1016/j.ejca.2019.10.014. [Epub ahead of print]

3.

Prognostic Factors in a Large Nationwide Cohort of Histologically Confirmed Primary and Secondary Angiosarcomas.

Weidema ME, Flucke UE, van der Graaf WTA, Ho VKY, Hillebrandt-Roeffen MHS; Dutch Nationwide Network and Registry of Histo- and Cytopathology (PALGA)-Group, Versleijen-Jonkers YMH, Husson O, Desar IME.

Cancers (Basel). 2019 Nov 12;11(11). pii: E1780. doi: 10.3390/cancers11111780.

4.

Genetic Alterations at Diagnosis Predict Outcome of AML Patients Age 60 or Older Undergoing Allogeneic Transplantation in First Remission.

Murdock HM, Kim HT, Hambley B, Vachhani P, Denlinger N, Gier SH, Cho C, Perales MA, Koreth J, Ho VT, Soiffer RJ, McCurdy SR, Carroll M, Vasu S, Wang ES, Gondek LP, Devine S, Alyea EP, Gibson CJ, Lindsley RC.

Blood. 2019 Nov 13;134(Supplement_1):48. doi: 10.1182/blood-2019-125967.

PMID:
31724009
5.

Incidence, Predictors, and Outcomes of Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome after Reduced-Intensity Allogeneic Hematopoietic Cell Transplantation.

Lewis C, Kim HT, Roeker LE, Cutler C, Koreth J, Nikiforow S, Armand P, Gootpu M, Romee R, Glotzbecker B, Nageshwar P, Antin JH, Alyea EP, Richardson P, Soiffer RJ, Ho VT.

Biol Blood Marrow Transplant. 2019 Oct 31. pii: S1083-8791(19)30706-2. doi: 10.1016/j.bbmt.2019.10.024. [Epub ahead of print]

PMID:
31678537
6.

Vaccination Guidelines for Patients with Immune-Mediated Disorders on Immunosuppressive Therapies-Executive Summary.

Papp KA, Haraoui B, Kumar D, Marshall JK, Bissonnette R, Bitton A, Bressler B, Gooderham M, Ho V, Jamal S, Pope JE, Steinhart AH, Vinh DC, Wade J.

J Can Assoc Gastroenterol. 2019 Dec;2(4):149-152. doi: 10.1093/jcag/gwy069. Epub 2019 Feb 1.

7.

A phase II study of reduced intensity double umbilical cord blood transplantation using fludarabine, melphalan, and low dose total body irradiation.

DeFilipp Z, Li S, Avigan D, Armand P, Ho VT, Koreth J, Nikiforow S, Alyea EP, Ritz J, Boussiotis V, Rosenblatt J, Brown J, McAfee S, Dey BR, El-Jawahri A, Spitzer TR, Chen YB, Soiffer RJ, Antin JH, Ballen KK, Cutler CS.

Bone Marrow Transplant. 2019 Oct 15. doi: 10.1038/s41409-019-0715-x. [Epub ahead of print]

PMID:
31616065
8.

DNA Methylation Profiling Identifies Distinct Clusters in Angiosarcomas.

Weidema ME, van de Geer E, Koelsche C, Desar IME, Kemmeren P, Hillebrandt-Roeffen MHS, Ho VKY, van der Graaf WTA, Versleijen-Jonkers YMH, von Deimling A, Flucke UE; PALGA Group.

Clin Cancer Res. 2019 Sep 27. doi: 10.1158/1078-0432.CCR-19-2180. [Epub ahead of print]

PMID:
31562204
9.

Physical capacity outcomes in patients with severe obesity after 12 months of physician-led multidisciplinary team care: A case series from a public hospital clinical obesity service.

Atlantis E, Langford K, Piya M, Ho V, Skelsey K, Rickards L, Edwards S, Kormas N.

Clin Obes. 2019 Dec;9(6):e12337. doi: 10.1111/cob.12337. Epub 2019 Sep 1.

PMID:
31475476
10.

Dose-escalated interleukin-2 therapy for refractory chronic graft-versus-host disease in adults and children.

Whangbo JS, Kim HT, Mirkovic N, Leonard L, Poryanda S, Silverstein S, Kim S, Reynolds CG, Rai SC, Verrill K, Lee MA, Margossian S, Duncan C, Lehmann L, Huang J, Nikiforow S, Alyea EP 3rd, Armand P, Cutler CS, Ho VT, Blazar BR, Antin JH, Soiffer RJ, Ritz J, Koreth J.

Blood Adv. 2019 Sep 10;3(17):2550-2561. doi: 10.1182/bloodadvances.2019000631.

11.

Allogeneic Stem Cell Transplantation Provides Durable Remission in Patients with Primary Mediastinal Large B Cell Lymphoma.

Herrera AF, Chen L, Khajavian S, Chase M, Darrah J, Maloney D, Ho VT, Soiffer RJ, Antin JH, Forman SJ, Nademanee AP, Chen YB, Armand P, Shadman M.

Biol Blood Marrow Transplant. 2019 Dec;25(12):2383-2387. doi: 10.1016/j.bbmt.2019.07.041. Epub 2019 Aug 5.

PMID:
31394277
12.

Peripheral nerve stimulation limits of a high amplitude and slew rate magnetic field gradient coil for neuroimaging.

Tan ET, Hua Y, Fiveland EW, Vermilyea ME, Piel JE, Park KJ, Ho VB, Foo TKF.

Magn Reson Med. 2020 Jan;83(1):352-366. doi: 10.1002/mrm.27909. Epub 2019 Aug 6.

PMID:
31385628
13.

Recurrent genetic HLA loss in AML relapsed after matched unrelated allogeneic hematopoietic cell transplantation.

Jan M, Leventhal MJ, Morgan EA, Wengrod JC, Nag A, Drinan SD, Wollison BM, Ducar MD, Thorner AR, Leppanen S, Baronas J, Stevens J, Lane WJ, Kekre N, Ho VT, Koreth J, Cutler CS, Nikiforow S, Alyea EP 3rd, Antin JH, Soiffer RJ, Ritz J, Lindsley RC, Ebert BL.

Blood Adv. 2019 Jul 23;3(14):2199-2204. doi: 10.1182/bloodadvances.2019000445.

14.

A Practical Management Approach to Gastroparesis.

Longley K, Ho V.

Intern Med J. 2019 Jul 17. doi: 10.1111/imj.14438. [Epub ahead of print] Review.

PMID:
31314176
15.

Between-hospital variation in mortality and survival after glioblastoma surgery in the Dutch Quality Registry for Neuro Surgery.

De Witt Hamer PC, Ho VKY, Zwinderman AH, Ackermans L, Ardon H, Boomstra S, Bouwknegt W, van den Brink WA, Dirven CM, van der Gaag NA, van der Veer O, Idema AJS, Kloet A, Koopmans J, Ter Laan M, Verstegen MJT, Wagemakers M, Robe PAJT; Quality Registry Neuro Surgery glioblastoma working group from the Dutch Society of Neurosurgery.

J Neurooncol. 2019 Sep;144(2):313-323. doi: 10.1007/s11060-019-03229-5. Epub 2019 Jun 24.

16.

Severe Herpes Zoster Requiring Intravenous Antiviral Treatment in Allogeneic Hematopoietic Cell Transplantation Recipients on Standard Acyclovir Prophylaxis.

Baumrin E, Cheng MP, Kanjilal S, Ho VT, Issa NC, Baden LR.

Biol Blood Marrow Transplant. 2019 Aug;25(8):1642-1647. doi: 10.1016/j.bbmt.2019.04.015. Epub 2019 Apr 17.

PMID:
31004745
17.

Functional analysis of clinical response to low-dose IL-2 in patients with refractory chronic graft-versus-host disease.

Whangbo JS, Kim HT, Nikiforow S, Koreth J, Alho AC, Falahee B, Kim S, Dusenbury K, Fields MJ, Reynolds CG, Alyea EP 3rd, Armand P, Cutler CS, Ho VT, Antin JH, Soiffer RJ, Ritz J.

Blood Adv. 2019 Apr 9;3(7):984-994. doi: 10.1182/bloodadvances.2018027474.

18.

Efficacy and immunologic effects of extracorporeal photopheresis plus interleukin-2 in chronic graft-versus-host disease.

Belizaire R, Kim HT, Poryanda SJ, Mirkovic NV, Hipolito E, Savage WJ, Reynolds CG, Fields MJ, Whangbo J, Kubo T, Nikiforow S, Alyea EP, Armand P, Cutler CS, Ho VT, Blazar BR, Antin JH, Ritz J, Soiffer RJ, Koreth J.

Blood Adv. 2019 Apr 9;3(7):969-979. doi: 10.1182/bloodadvances.2018029124.

19.

Bone sarcoma incidence in the Netherlands.

Goedhart LM, Ho VKY, Dijkstra PDS, Schreuder HWB, Schaap GR, Ploegmakers JJW, van der Geest ICM, van de Sande MAJ, Bramer JA, Suurmeijer AJH, Jutte PC.

Cancer Epidemiol. 2019 Jun;60:31-38. doi: 10.1016/j.canep.2019.03.002. Epub 2019 Mar 20.

PMID:
30903831
20.

Comparing DNA methylation profiles in saliva and intestinal mucosa.

Hearn NL, Coleman AS, Ho V, Chiu CL, Lind JM.

BMC Genomics. 2019 Feb 28;20(1):163. doi: 10.1186/s12864-019-5553-0.

Supplemental Content

Loading ...
Support Center